Lung Cancer

Liquid Biopsy Technology Detects Over 95% of Early-Stage Cancers in Blinded Validation Study

A novel enrichment method produces virtually pure circulating tumor DNA from blood samples, showing strong sensitivity and specificity across colorectal and lung cancer patients.

Lung Cancer

Why Closing Lung Cancer’s Diagnostic Gap Will Require New Lab Strategies

On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.

Lung Cancer

Roche Receives FDA Nod for Lung Cancer Companion Diagnostic

The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic for lung cancer.

AI-based Classifiers for Lung Cancer Subtyping Findings Presented

Dec 20, 2024 | Lung Cancer

The results of AI-based classifiers for lung cancer using Qlucore Insights were recently presented by researchers.

Biofidelity’s Aspyre Lung Delivers Accurate Molecular Diagnostics for NSCLC Variants

Dec 3, 2024 | Lung Cancer, Molecular Diagnostics

Studies validated Biofidelity’s Aspyre Lung diagnostic tech, showcasing its ability to offer genomic profiling for actionable NSCLC variants.

Biofidelity Launches Test Offering Rapid Genomic Profiling for NSCLC Patients

Nov 21, 2024 | Lung Cancer, Molecular Diagnostics

Biofidelity’s test delivers comprehensive genomic profiling for NSCLC patients from tissue or liquid biopsy samples within two days.

Roche and Sheba Medical Center Partner to Improve NSCLC Diagnosis Using AI-Powered Digital Pathology

Nov 20, 2024 | Digital Pathology, Lung Cancer

Roche and Sheba Medical Center’s ARC are collaborating to enhance NSCLC diagnosis and treatment using AI-driven digital pathology tools.

Mesothelioma Cancer Detection May Improve with New Test

Nov 18, 2024 | Lung Cancer

Researchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.

Nanowire-Based Urine Test with AI Detects Early-Stage Lung Cancer with High Accuracy

Nov 15, 2024 | Lung Cancer, Urine Analyzers

Researchers developed a non-invasive cancer detection tool using nanowire-based miRNA extraction and AI to identify lung cancer in urine.

New Blood Test Detects Drug-Induced Tissue Damage in Cancer Patients Early

Nov 12, 2024 | Lung Cancer

A blood test identifies early lung damage in cancer patients taking antibody–drug conjugates, offering an alternative to imaging scans.

Researchers Develop Robotic Sensory Cilia that Detect Airway Diseases

Nov 7, 2024 | Diagnostic Technologies, Lung Cancer

The system enables detection and personalized care for diseases like Cystic Fibrosis, Chronic Obstructive Pulmonary Diseases, and lung cancer.

Detecting Evidence of Lung Cancer in Exhaled Breath

Nov 6, 2024 | Lung Cancer

Researchers developed a sensor that can detect low levels of isoprene in exhaled breath, potentially enabling early lung cancer diagnosis.

NeoGenomics’ Solid Tumor Test Gets New York State Approval

Oct 22, 2024 | Lung Cancer, Molecular Diagnostics

NeoGenomics received conditional approval from the New York State Department of Health for its Neo Comprehensive Solid Tumor and NeoTYPE DNA & RNA Lung assays.